KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Income from Non-Controlling Interests: 2009-2024

Historic Income from Non-Controlling Interests for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -$320.0 million.

  • Teva Pharmaceutical Industries' Income from Non-Controlling Interests fell 97.87% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year increase of 98.45%. This contributed to the annual value of -$320.0 million for FY2024, which is 471.43% down from last year.
  • As of FY2024, Teva Pharmaceutical Industries' Income from Non-Controlling Interests stood at -$320.0 million, which was down 471.43% from -$56.0 million recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' Income from Non-Controlling Interests registered a high of $39.0 million during FY2021, and its lowest value of -$320.0 million during FY2024.
  • Its 3-year average for Income from Non-Controlling Interests is -$143.0 million, with a median of -$56.0 million in 2023.
  • In the last 5 years, Teva Pharmaceutical Industries' Income from Non-Controlling Interests crashed by 5,350.00% in 2020 and then spiked by 135.78% in 2021.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Income from Non-Controlling Interests stood at -$109.0 million in 2020, then surged by 135.78% to $39.0 million in 2021, then plummeted by 235.90% to -$53.0 million in 2022, then decreased by 5.66% to -$56.0 million in 2023, then tumbled by 471.43% to -$320.0 million in 2024.